LBO — PORTNEUF MEDICAL CENTER
IRR: 16.0% | MOIC: 2.10x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
16.0%
IRR
2.10x
MOIC
$537.5M
Entry EV
$791.3M
Exit EV
$276.6M
Equity Invested
Sources & Uses
S&UTotal · $537.5M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $208.7M | 38.8% | |
| Sub Debt | $52.2M | 9.7% | |
| Equity | $276.6M | 51.5% | |
| Enterprise Value | $521.8M | 97.1% | |
| Transaction Fees | $15.7M | 2.9% | |
| Total Uses | $537.5M | 100.0% |
Interpretation
INTAt 2.10x MOIC and 16.0% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $75.4M |
| Exit Ev | $791.3M |
| Net Debt At Exit | $210.1M |
| Equity At Exit | $581.2M |
| Equity Invested | $276.6M |
| Total Value Created | $304.7M |
| Value From Growth | $243.4M |
| Value From Multiple | $26.1M |
| Value From Deleveraging | $50.9M |